atorvastatin krka 40 mg filmsko obložene tablete
billev pharma aps - atorvastatin - filmsko obložena tableta - atorvastatin 40 mg / 1 tableta - atorvastatin
atorvastatin krka 10 mg filmsko obložene tablete
billev pharma aps - atorvastatin - filmsko obložena tableta - atorvastatin 10 mg / 1 tableta - atorvastatin
telmisartan/hidroklorotiazid krka 80 mg/25 mg tablete
billev pharma aps - hidroklorotiazid; telmisartan - tableta - hidroklorotiazid 25 mg / 1 tableta telmisartan80 mg / 1 tableta; telmisartan 80 mg / 1 tableta - telmisartan in diuretiki
telmisartan/hidroklorotiazid krka 80 mg/12,5 mg tablete
billev pharma aps - hidroklorotiazid; telmisartan - tableta - hidroklorotiazid 12,5 mg / 1 tableta telmisartan80 mg / 1 tableta; telmisartan 80 mg / 1 tableta - telmisartan in diuretiki
cefenil rtu
norbrook laboratories (ireland) ltd -
porcilis app
intervet international -
cadorex raz za injic
livisto int’l -
nuflor raztopina za injiciranje
intervet international -
tilmicosol
lavet pharmaceuticals ltd -
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imunski sera in imunoglobulini, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.